Skip to main content

Research Repository

Advanced Search

Increased NLRP1 mRNA and Protein Expression Suggests Inflammasome Activation in the Dorsolateral Prefrontal and Medial Orbitofrontal Cortex in Schizophrenia

Španić Popovački, Ena; Vogrinc, Dora; Fuller, Heidi; Langer Horvat, Lea; Mayer, Davor; Kopić, Janja; Pintarić, Klara; Babić Leko, Mirjana; Pravica, Mihaela; Krsnik, Željka; Marčinko, Darko; Šagud, Marina; Hof, Patrick; Mladinov, Mihovil; Šimić, Goran

Authors

Ena Španić Popovački

Dora Vogrinc

Lea Langer Horvat

Davor Mayer

Janja Kopić

Klara Pintarić

Mirjana Babić Leko

Mihaela Pravica

Željka Krsnik

Darko Marčinko

Marina Šagud

Patrick Hof

Mihovil Mladinov

Goran Šimić



Abstract

Schizophrenia is a complex mental condition, with key symptoms marked for diagnosis including delusions, hallucinations, disorganized thinking, reduced emotional expression, and social dysfunction. In the context of major developmental hypotheses of schizophrenia, notably those concerning maternal immune activation and neuroinflammation, we studied NLRP1 expression and content in the postmortem brain tissue of 10 schizophrenia and 10 control subjects. In the medial orbitofrontal cortex (Brodmann’s area 11/12) and dorsolateral prefrontal cortex (area 46) from both hemispheres of six schizophrenia subjects, the NLRP1 mRNA expression was significantly higher than in six control brains (p < 0.05). As the expression difference was highest for the medial orbitofrontal cortex in the right hemisphere, we assessed NLRP1-immunoreactive pyramidal neurons in layers III, V, and VI in the medial orbitofrontal cortex in the right hemisphere of seven schizophrenia and five control brains. Compared to controls, we quantified a significantly higher number of NLRP1-positive pyramidal neurons in the schizophrenia brains (p < 0.01), suggesting NLRP1 inflammasome activation in schizophrenia subjects. Layer III pyramidal neuron dysfunction aligns with working memory deficits, while impairments of pyramidal neurons in layers V and VI likely disrupt predictive processing. We propose NLRP1 inflammasome as a potential biomarker and therapeutic target in schizophrenia.

Citation

Španić Popovački, E., Vogrinc, D., Fuller, H., Langer Horvat, L., Mayer, D., Kopić, J., Pintarić, K., Babić Leko, M., Pravica, M., Krsnik, Ž., Marčinko, D., Šagud, M., Hof, P., Mladinov, M., & Šimić, G. (2024). Increased NLRP1 mRNA and Protein Expression Suggests Inflammasome Activation in the Dorsolateral Prefrontal and Medial Orbitofrontal Cortex in Schizophrenia. Biomolecules, 14(3), Article 302. https://doi.org/10.3390/biom14030302

Journal Article Type Article
Acceptance Date Feb 29, 2024
Online Publication Date Mar 4, 2024
Publication Date Mar 4, 2024
Deposit Date Feb 29, 2024
Publicly Available Date Mar 20, 2024
Journal Biomolecules
Electronic ISSN 2218-273X
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 14
Issue 3
Article Number 302
DOI https://doi.org/10.3390/biom14030302
Keywords schizophrenia; NLRP1 inflammasome; predictive processing; prefrontal cortex; pyram-idal neurons.
Public URL https://keele-repository.worktribe.com/output/758487

Files






You might also like



Downloadable Citations